-
Mashup Score: 33Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial - 2 month(s) ago
Background: Stopping aspirin within 1 month after implantation of a drug-eluting stent (DES) for ticagrelor monotherapy has not been exclusively evaluated for patients with acute coronary syndrome (A
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3TAVI at 20: how a crazy idea led to a clinical revolution - 3 month(s) ago
This article discusses the 20 year history of the development of transcatheter aortic valve implantation as a treatment for severe aortic stenosis.
Source: eurointervention.pcronline.comCategories: General Medicine News, CardiologistsTweet-
How a crazy idea led to a clinical revolution. "To all those who believe that we as cardiologists can make a difference in our commitment to ideas, TAVI stands as an example of what such an idea can produce." Rest in peace, Prof. Cribier. https://t.co/WV077qkMrN https://t.co/cAK4SbuMUK https://t.co/aAyb0QSZiM
-
-
Mashup Score: 3TAVI at 20: how a crazy idea led to a clinical revolution - 3 month(s) ago
This article discusses the 20 year history of the development of transcatheter aortic valve implantation as a treatment for severe aortic stenosis.
Source: eurointervention.pcronline.comCategories: General Medicine News, CardiologistsTweet-
How a crazy idea led to a clinical revolution. "To all those who believe that we as cardiologists can make a difference in our commitment to ideas, TAVI stands as an example of what such an idea can produce." Rest in peace, Prof. Cribier. https://t.co/WV077qkMrN https://t.co/cAK4SbuMUK https://t.co/aAyb0QSZiM
-
-
Mashup Score: 3TAVI at 20: how a crazy idea led to a clinical revolution - 3 month(s) ago
This article discusses the 20 year history of the development of transcatheter aortic valve implantation as a treatment for severe aortic stenosis.
Source: eurointervention.pcronline.comCategories: General Medicine News, CardiologistsTweet-
How a crazy idea led to a clinical revolution. "To all those who believe that we as cardiologists can make a difference in our commitment to ideas, TAVI stands as an example of what such an idea can produce." Rest in peace, Prof. Cribier. https://t.co/WV077qkMrN https://t.co/cAK4SbuMUK https://t.co/aAyb0QSZiM
-
-
Mashup Score: 47Towards AI-assisted cardiology: a reflection on the performance and limitations of using large language models in clinical decision-making - 5 month(s) ago
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Source: eurointervention.pcronline.comCategories: General Medicine News, CardiologistsTweet-
In this article, discussing the performance and limitations of using AI in clinical decision-making, the authors designed two clinical vignettes that were presented to #ChatGPT, and found significantly different responses based on query presentation... https://t.co/O5ztVr22gH https://t.co/l6njP8XOhw
-
-
Mashup Score: 126
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Source: eurointervention.pcronline.comCategories: General Medicine News, CardiologistsTweet-
In the OPERA-TAVI registry, matched patients undergoing TAVI using Evolut PRO/PRO+ and Sapien 3 ULTRA devices exhibited comparable rates of the composite endpoint of all-cause mortality, rehospitalisation for heart failure, or disabling stroke at 1 year. https://t.co/BlZWQ6FGPN https://t.co/2O5bEYKEku
-
-
Mashup Score: 127Evaluating the pharmacokinetic and pharmacodynamic impact of different modes of ticagrelor administration - 6 month(s) ago
Alternative administration modes for oral P2Y12 inhibitors, particularly ticagrelor, have emerged as a potential alternative to overcome the limitations associated with the delayed onset of action …
Source: www.tandfonline.comCategories: General Medicine News, CardiologistsTweet-
Alternative administration modes for ticagrelor (i.e., crushed, chewed, or orodispersible tablets) are an alternative to overcome the limitations associated with its delayed onset of action in patients who are unable to swallow or with impaired absorption. https://t.co/sgDyfJX0M6 https://t.co/UzCaTUbnw4
-
-
Mashup Score: 155Prognostic impact of cardiac damage staging classification in each aortic stenosis subtype undergoing TAVI - 6 month(s) ago
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Source: eurointervention.pcronline.comCategories: General Medicine News, CardiologistsTweet-
In this prospective TAVI registry of 2,090 patients across the hemodynamic spectrum of severe aortic stenosis, the cardiac damage staging classification stratified the risk of death irrespective of aortic stenosis subtypes (e.g., high or low gradient). https://t.co/THeg0k7BGd https://t.co/9m7xjOS2KT
-
-
Mashup Score: 154Prognostic impact of cardiac damage staging classification in each aortic stenosis subtype undergoing TAVI - 6 month(s) ago
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Source: eurointervention.pcronline.comCategories: General Medicine News, CardiologistsTweet-
In this prospective TAVI registry of 2,090 patients across the hemodynamic spectrum of severe aortic stenosis, the cardiac damage staging classification stratified the risk of death irrespective of aortic stenosis subtypes (e.g., high or low gradient). https://t.co/THeg0k7BGd https://t.co/9m7xjOS2KT
-
-
Mashup Score: 33Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial - 6 month(s) ago
Background: Stopping aspirin within 1 month after implantation of a drug-eluting stent (DES) for ticagrelor monotherapy has not been exclusively evaluated for patients with acute coronary syndrome (A
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
In T-PASS, aspirin discontinuation after a median of 16 days, followed by ticagrelor monotherapy, was superior for NACE compared with 12-mo DAPT in 2850 patients with ACS, with less bleeding. But KM curves opened late, which is a bit puzzling. #TCT2023 https://t.co/GAEGEpykmL